Cologne Cohort of Neutropenic Patients (CoCoNut)

The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hematological Malignancies Agranulocytosis Cancer Chemotherapy Cytopenia Hematologic Diseases Hematologic Neoplasms Hemic and Lymphatic Diseases Immunosuppression Leukocyte Disorders Leukopenia Neoplasms Neoplasms by Site Neutropenia

Age range

1 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Cologne

Cologne, North Rhine-Westphalia, 50924, Germany

Location status: Recruiting

About this study

This prospective cohort was established with the aim of a comprehensive data collection of all patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

immunosuppressed patients

Exclusion criteria

none

Treatment and study plan

Antiinfectives

Drug

To analyze to efficacy of (novel) drug therapies

Other names: Antifungals, Antibacterials, Antivirals

Primary outcomes

Long-term survival of hematology and oncology patients following neutropenia

Time frame: 2 years following last follow-up

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

University Hospital of Cologne

Other

Registry information

Official study title

The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections

Acronym: CoCoNut

Important dates

Study start: 1995
Primary completion: 2050
Study completion: 2050
First posted: Apr 1, 2013
Registry last updated: Apr 1, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not yet recruiting